Brief: Simulations Plus Receives U.S. FDA Renewal For Dilisym Software Licenses

Simulations Plus

18/04/2023 13:35

April 18 (Reuters) - Simulations Plus Inc  SLP.O :
    * SIMULATIONS PLUS RECEIVES U.S. FDA RENEWAL FOR DILISYM
SOFTWARE
LICENSES
    * SIMULATIONS PLUS INC - PROVIDES FDA WITH SOFTWARE TOOLS TO
INVESTIGATE DRUG-INDUCED LIVER INJURY IN CLINICAL TRIALS

Source text for Eikon:  ID:nBw4Qwpm0a 
Further company coverage:  SLP.O